Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.4 USD | +0.50% | +5.07% | +9.32% |
12:18am | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
07/06 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.32% | 30TCr | |
+45.82% | 77TCr | |
+40.95% | 63TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+18.45% | 25TCr | |
-0.78% | 22TCr | |
+11.88% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Abbvie Insider Sold Shares Worth $9,184,048, According to a Recent SEC Filing